The Silicon Forest in Hillsboro, OR, January 9, 2024 – The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Did you know that cc-TDI is home to our very own bio-banking registry known as CuRe-FAST? In 2015, Dr. Keller and the cc-TDI team recognized
Recently, we collected multiple clear cell sarcoma cell lines and we are in the process of sequencing these cells so that we can learn more
As the newest lab member at cc-TDI, I began research on clear cell sarcoma in late November of 2018. My immediate goal is to collect
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
Since pediatric cancers are (fortunately!) fairly rare, it’s ever more important for us to do our work with the spirit of collaboration. Thanks to the
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
My name is Dr. Jody Hooper, MD, and I am the Director of the Legacy Gift Rapid Autopsy Program and Director of Autopsy at Johns
What a week! Our 2018 Nanocourse wrapped up last week, and what an amazing week it was. For those of you who are curious, the
Science Nonfiction: By Dina Kats One of the most rewarding things about working at cc-TDI is our community spirit. This past month I got to
Guest post by summer intern, Kelley Traller. Artwork by Kelley as well! My name is Kelley Traller, and I am an intern here at cc-TDI.
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
cc-TDI receives grant from Iron Matt to pursue promising new gene target for Diffuse Intrinsic Pontine Glioma The Matthew “Iron Matt” Larson Foundation for Pediatric
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
The Silicon Forest in Hillsboro, OR, January 9, 2024 – The Children’s Cancer Therapy Development Institute was awarded $100,000 in continued support of two research
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Did you know that cc-TDI is home to our very own bio-banking registry known as CuRe-FAST? In 2015, Dr. Keller and the cc-TDI team recognized
Recently, we collected multiple clear cell sarcoma cell lines and we are in the process of sequencing these cells so that we can learn more
As the newest lab member at cc-TDI, I began research on clear cell sarcoma in late November of 2018. My immediate goal is to collect
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
Scientists at cc-TDI have uncovered a drug that turns off the key gene in childhood muscle cancer. [Press Release] PORTLAND, OR – NOVEMBER 20, 2018
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
My name is Dr. Tohru Hosoyama, Ph.D., and I am the section chief of the Department of Regenerative Medicine at National Center for Geriatrics and
Since pediatric cancers are (fortunately!) fairly rare, it’s ever more important for us to do our work with the spirit of collaboration. Thanks to the
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
My name is Dr. Jody Hooper, MD, and I am the Director of the Legacy Gift Rapid Autopsy Program and Director of Autopsy at Johns
What a week! Our 2018 Nanocourse wrapped up last week, and what an amazing week it was. For those of you who are curious, the
Science Nonfiction: By Dina Kats One of the most rewarding things about working at cc-TDI is our community spirit. This past month I got to
Guest post by summer intern, Kelley Traller. Artwork by Kelley as well! My name is Kelley Traller, and I am an intern here at cc-TDI.
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
cc-TDI receives grant from Iron Matt to pursue promising new gene target for Diffuse Intrinsic Pontine Glioma The Matthew “Iron Matt” Larson Foundation for Pediatric
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
Each week we will be featuring the work of a scientist on the cc-TDI team to give you a view into the lab and an
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute